- Global Pharma News & Resources

Enteral Nutrition Market size was estimated to be valued at US$ 2,635.9 million in 2020, progressing at a CAGR of 5.8% during the forecast period

Enteral nutrition, also known as tube feeding, refers to any method of feeding that uses the gastrointestinal (GI) tract to deliver caloric requirements, including normal oral diet or liquid supplements. Nasoenteral, also known as nasogastric tube feeding, involves inserting a tube in the stomach through the nose. Whereas, a jejunostomy tube is placed directly through the skin. The tube feeding formula is used in patients suffering from chronic conditions including head trauma, cancer, and strokes. Moreover, the formula helps premature infants to gain required nutrition and medications. According to the National Center for Biotechnology Information (NCBI), nasogastric tubes are the most preferred method for short term feeding in the acute phase of stroke and are commonly used for providing nutrition, hydration, and essential medications.

Request Here For PDF Brochure @

Major factors propelling growth of the global enteral nutrition market are rising prevalence of chronic diseases such as diabetes, heart disease, and cancer, coupled with increasing health care expenditure across the globe. According to the American Diabetes Association (ADA), long term use of nutritional support with diabetes-specific formula helps in reducing chronic complications of diabetes such as cardiovascular diseases. According to the National Center for Biotechnology Information (NCBI), the use of enteral nutrition is helpful in patients with chronic heart failure (CHF). Furthermore, according to the Office for National Statistics, in the U.K., total health care expenditure was US$ 239.92 billion in 2014, which increased by 3.6% to US$ 248.51 billion in 2015. High health care expenditure of a region explains the affordability of expensive medical services. This in turn, is expected to support the overall growth of the enteral nutrition market as tube feeding is costlier compared to feeding without tubes. Enteral nutrition is used for patients across all age groups, however, the geriatric population segment is the most lucrative segment. Health concerns such as metabolic disorders and loss of appetite are more prevalent among the geriatric population, therefore, the growing geriatric population across the globe is projected to facilitate the market growth.

Complications associated with enteral nutrition include patient safety risks and feeding and medication errors. These are expected restrain growth of this market growth. For instance, according to the NCBI, placing a nasogastric tube can lead to various health problems such as gastrointestinal complications, aspiration, mechanical complications, and metabolic complications.

North America dominated the enteral nutrition market in 2016, and accounted for over 30% of the market share. The market is expected to retain its dominance throughout the forecast period (2017–2025). The increasing geriatric population in the region, coupled with the rising incidence of chronic illnesses are some of the factors complementing growth of the enteral nutrition market in North America. According to the Centers for Disease Control and Prevention (CDC), heart diseases, cancer, diabetes and strokes were the leading causes of disability and death in the U.S. in 2016. Moreover, according to the National Cancer Institute, in 2016, around 1.6 million patients were diagnosed with cancer in the U.S., out of which 0.59 million died from the disease. These factors are responsible for increased use of enteral nutrition in the U.S., thereby fuelling growth of the market in North America.

Asia Pacific is projected to be the fastest growing market for enteral nutrition, and exhibit a CAGR of 6.35% over the forecast period with India and China accounting for major market share. China and India have high proportion of geriatric population. According to the United Nations Economic and Social Commission for Asia and Pacific (UNESCAP), the geriatric population in Asia Pacific is rising significantly. In 2016, the proportion of geriatric population in North East Asia was around 17%, which is expected to cross 35%. Whereas, in North and Central Asia it is projected to cross 20% by 2050. Furthermore, diabetes has become a major health concern in this region.

According to data provided by the National Center for Biotechnology Information (NCBI), in 2014, the region accounted for around 150 million diabetic patients, out of which, over 95% had type 2 diabetes (T2DM). Furthermore, according to the World Health Organization (WHO), in 2016, China had a high diabetic population of around 110 million and the number is expected to increase to 150 million by 2040. However, China’s healthcare spending has increased significantly over the past decade, from US$ 90.8 billion in 2004 to US$ 590.2 billion in 2014 and it is expected to increase further. The growing healthcare expenditure is expected to boost the market growth. These factors are expected to strongly support growth of the enteral nutrition market in Asia Pacific in the near future.

Among disease type, chronic segment accounted for the largest market share in 2016 and is expected to retain its dominance throughout the forecast period. The rising number of chronic diseases such as cancer, cardiovascular diseases, and diabetes worldwide is propelling demand for enteral nutrition. According to the World Health Organization (WHO), in 2015, out of 56.4 million global deaths, around 70% were due to non-communicable diseases (NCDs), which include cardiovascular diseases, diabetes, cancer, and chronic lung diseases.

Major Key Players Include In Enteral Nutrition Market: Abbott Laboratories, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., and Curtis Health Caps SP.

Main points in Enteral Nutrition Market Report Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Enteral Nutrition Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Enteral Nutrition Industry Impact

Chapter 2 Global Enteral Nutrition Competition by Types, Applications, and Top Regions and Countries
2.1 Global Enteral Nutrition (Volume and Value) by Type
2.3 Global Enteral Nutrition (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Enteral Nutrition Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Enteral Nutrition Market Analysis
Chapter 6 East Asia Enteral Nutrition Market Analysis
Chapter 7 Europe Enteral Nutrition Market Analysis
Chapter 8 South Asia Enteral Nutrition Market Analysis
Chapter 9 Southeast Asia Enteral Nutrition Market Analysis
Chapter 10 Middle East Enteral Nutrition Market Analysis
Chapter 11 Africa Enteral Nutrition Market Analysis
Chapter 12 Oceania Enteral Nutrition Market Analysis
Chapter 13 South America Enteral Nutrition Market Analysis
Chapter 14 Company Profiles and Key Figures in Enteral Nutrition Business
Chapter 15 Global Enteral Nutrition Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology


Buy instant copy of this research report with Flat US $ 2000 Off@

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 27-Sep-2021